These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 33616317

  • 1. Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
    Ji M, Na N, Lin S.
    Clin Lab; 2021 Feb 01; 67(2):. PubMed ID: 33616317
    [Abstract] [Full Text] [Related]

  • 2. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    Cao X, Yao J, Jia M, Shen X, Zhang J, Ju S.
    J Ovarian Res; 2022 Feb 03; 15(1):20. PubMed ID: 35115025
    [Abstract] [Full Text] [Related]

  • 3. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
    Zhang J, Dong D, Wei Q, Ren L.
    BMC Cancer; 2022 Oct 08; 22(1):1052. PubMed ID: 36207693
    [Abstract] [Full Text] [Related]

  • 4. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S.
    Acta Obstet Gynecol Scand; 2002 May 08; 81(5):451-7. PubMed ID: 12027820
    [Abstract] [Full Text] [Related]

  • 5. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
    Farzaneh F, Shahghassempour S, Noshine B, Arab M, Yaseri M, Rafizadeh M, Alizadeh K.
    Asian Pac J Cancer Prev; 2014 May 08; 15(9):3911-4. PubMed ID: 24935573
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
    Gaarenstroom KN, Bonfrer JM, Kenter GG, Korse CM, Hart AA, Trimbos JB, Helmerhorst TJ.
    Cancer; 1995 Sep 01; 76(5):807-13. PubMed ID: 8625184
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 8. The Level of Squamous Cell Carcinoma Antigen and Lymph Node Metastasis in Locally Advanced Cervical Cancer.
    Lekskul N, Charakorn C, Lertkhachonsuk AA, Rattanasiri S, Israngura Na Ayudhya N.
    Asian Pac J Cancer Prev; 2015 May 23; 16(11):4719-22. PubMed ID: 26107230
    [Abstract] [Full Text] [Related]

  • 9. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG.
    J Clin Oncol; 1996 Jan 23; 14(1):111-8. PubMed ID: 8558185
    [Abstract] [Full Text] [Related]

  • 10. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V, Lubrano A, Pérez-Regadera JF, Torné A, Gil-Moreno A, Tejerizo-Garcia Á, Vergés R, Díaz-Feijoo B, SEGO Spain-GOG Group.
    Gynecol Oncol; 2021 Aug 23; 162(2):407-412. PubMed ID: 34119366
    [Abstract] [Full Text] [Related]

  • 11. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L, Cheng J, Zhou M, Yao Z, Zhang Y.
    J Cancer Res Clin Oncol; 2012 Feb 23; 138(2):239-46. PubMed ID: 22102174
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.
    Ran C, Sun J, Qu Y, Long N.
    World J Surg Oncol; 2021 Dec 09; 19(1):343. PubMed ID: 34886853
    [Abstract] [Full Text] [Related]

  • 13. Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis.
    Shou H, Yasuo Y, Yuan S, Lou H, Ni J.
    Int J Gynaecol Obstet; 2021 Jan 09; 152(1):112-117. PubMed ID: 33141954
    [Abstract] [Full Text] [Related]

  • 14. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr 09; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E, Ławicki S.
    BMC Cancer; 2019 Apr 29; 19(1):398. PubMed ID: 31035945
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patients.
    Ławicki S, Będkowska GE, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Folia Histochem Cytobiol; 2012 Jul 04; 50(2):213-9. PubMed ID: 22763962
    [Abstract] [Full Text] [Related]

  • 17. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X.
    Int J Gynecol Cancer; 2017 Nov 04; 27(9):1935-1942. PubMed ID: 28914639
    [Abstract] [Full Text] [Related]

  • 18. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan 04; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 19. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 04; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 20. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Gao F, Wang Y, Li H, Yin J.
    Technol Health Care; 2024 Feb 04; 32(5):3083-3095. PubMed ID: 38848201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.